AIDX 20/20 Biolabs, Inc.

Fundamentals / CIK 0001139685 / USD

20/20 Biolabs, Inc. reported $2.00M in revenue and a net loss of $6.36M for the trailing twelve months ended September 30, 2026 (down 9.0% year over year), with a 29.7% gross margin and a -249.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AIDX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2024 to 2025), reported in USD.

$2.60M$1.30M$0-$5.36MFY 2024 Revenue: $1.75MFY 2024 Net Income: -$5.55M2024FY 2025 Revenue: $2.05MFY 2025 Net Income: -$3.74M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31
Revenue $2.05M $1.75M
Cost of Revenue $1.44M $1.39M
Gross Profit $605K $360K
Research & Development $593K $1.26M
Selling, General & Admin $3.34M $4.76M
Total Operating Expenses $3.94M $6.04M
Operating Income -$3.33M -$5.68M
EBITDA -$3.27M -$5.56M
Interest Income $21K $79K
Interest Expense $156K $13K
Net Income -$3.74M -$5.55M
Basic EPS -$0.76 -$1.16
Diluted EPS -$0.76 -$1.16
Basic Shares Outstanding 4.9M 4.8M
Diluted Shares Outstanding 4.9M 4.8M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Revenue $380K $731K $353K $538K $418K $535K $554K
Cost of Revenue $283K $426K $290K $408K $273K $372K $388K
Gross Profit $97K $305K $63K $130K $145K $163K $166K
Research & Development $123K $258K $153K $131K $131K $194K $137K
Selling, General & Admin $1.36M $1.29M $1.35M $913K $814K $815K $801K
Total Operating Expenses $1.49M $1.55M $1.51M $1.04M $945K $1.01M $938K
Operating Income -$1.39M -$1.24M -$1.44M -$913K -$800K -$846K -$772K
EBITDA -$1.38M -$1.23M -$1.43M -$898K -$785K -$830K -$754K
Interest Income $15K $14K $6.7K $3.1K $4.2K $5.7K $8.5K
Interest Expense -$1 $272K $267K $125K $30K $935 $740
Net Income -$1.38M -$1.51M -$2.17M -$1.31M -$826K -$841K -$765K
Basic EPS -$0.12 -$0.26 -$0.28 -- -$0.17 -$0.17 -$0.16
Diluted EPS -$0.12 -$0.26 -$0.28 -- -$0.17 -$0.17 -$0.16
Basic Shares Outstanding 13.0M 10.8M 7.7M -- 4.8M 4.8M 4.8M
Diluted Shares Outstanding 13.0M 10.8M 7.7M -- 4.8M 4.8M 4.8M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $1.03M $1.78M
Cash & Short-Term Investments $1.03M $1.78M
Accounts Receivable, Net $200K $135K
Inventory $116K $47K
Total Current Assets $1.47M $2.03M
Property, Plant & Equipment, Net $57K $117K
Intangible Assets $202K $206K
Other Non-Current Assets $23K $162K
Total Non-Current Assets $2.67M $1.55M
Total Assets $4.14M $3.58M
Accounts Payable $869K $372K
Deferred Revenue (Current) $415K $470K
Total Current Liabilities $2.46M $1.36M
Deferred Revenue (Non-Current) $42K $50K
Total Non-Current Liabilities $1.69M $724K
Total Liabilities $4.16M $2.08M
Total Debt (incl. Leases) $665K $840K
Common Stock $54K $48K
Retained Earnings -$33.25M -$29.51M
Total Stockholders' Equity -$19K $1.51M
Total Equity -$19K $1.51M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2024-12-31
Cash & Cash Equivalents $3.63M $4.55M $4.22M $1.03M $1.78M
Cash & Short-Term Investments $3.63M $4.55M $4.22M $1.03M $1.78M
Accounts Receivable, Net $174K $291K $201K $200K $135K
Inventory $103K $111K $105K $116K $47K
Total Current Assets $4.03M $5.08M $4.70M $1.47M $2.03M
Property, Plant & Equipment, Net $25K $34K $45K $57K $117K
Intangible Assets $205K $206K $207K $202K $206K
Other Non-Current Assets $23K $23K $23K $23K $162K
Total Non-Current Assets $988K $1.05M $1.10M $2.67M $1.55M
Total Assets $5.02M $6.12M $5.80M $4.14M $3.58M
Accounts Payable $1.05M $1.03M $980K $869K $372K
Deferred Revenue (Current) $479K $467K $451K $415K $470K
Total Current Liabilities $2.49M $2.55M $2.58M $2.46M $1.36M
Deferred Revenue (Non-Current) $29K $33K $37K $42K $50K
Total Non-Current Liabilities $359K $413K $466K $1.69M $724K
Total Liabilities $2.85M $2.96M $3.05M $4.16M $2.08M
Total Debt (incl. Leases) $526K $572K $619K $665K $840K
Common Stock $134K $123K $104K $54K $48K
Retained Earnings -$38.30M -$36.93M -$35.42M -$33.25M -$29.51M
Total Stockholders' Equity $611K $1.62M $2.55M -$19K $1.51M
Total Equity $611K $1.62M $2.55M -$19K $1.51M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31
Net Income -$3.74M -$5.55M
Depreciation & Amortization $63K $116K
Stock-Based Compensation $516K $2.18M
Change in Receivables -$65K -$66K
Change in Inventory -$69K $14K
Change in Payables $496K $12K
Operating Cash Flow -$1.92M -$2.60M
Financing Cash Flow $1.16M $293K
Net Change in Cash -$758K -$2.31M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$1.38M -$1.51M -$2.17M -$1.31M -$826K -$841K -$765K
Depreciation & Amortization $10.0K $12K $12K $15K $15K $15K $18K
Stock-Based Compensation $210K $371K $128K $127K $130K $130K $130K
Change in Receivables $118K -$90K -$1.5K -$63K $37K -$45K $5.6K
Change in Inventory $8.5K -$6.5K $12K -$61K $6.9K $6.4K -$21K
Change in Payables $97K $46K $112K $240K $72K $73K $111K
Operating Cash Flow -$912K -$605K -$1.29M -$512K -$386K -$534K -$488K
Investing Cash Flow $0 -$7.5K -$5.4K -- -- -- --
Financing Cash Flow $0 $940K $4.49M $393K $507K $0 $262K
Net Change in Cash -$912K $327K $3.19M -$119K $121K -$534K -$226K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31
Gross Margin 29.6% 20.6%
Operating Margin -162.9% -324.0%
Net Profit Margin -182.8% -316.8%
Return on Equity (ROE) -- -368.8%
Return on Assets (ROA) -90.4% -154.9%
Current Ratio 0.60x 1.50x
Quick Ratio 0.55x 1.47x
Debt to Equity -- 0.56x
Revenue Growth (YoY) +16.7% --
Gross Profit Growth (YoY) +67.8% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Gross Margin 29.7% 31.5% 27.2% 29.6% -- -- --
Operating Margin -249.2% -215.7% -216.9% -162.9% -- -- --
Net Profit Margin -317.8% -285.0% -279.1% -182.8% -- -- --
Return on Equity (ROE) -1041.2% -358.8% -201.7% -- -- -- --
Return on Assets (ROA) -126.8% -95.0% -88.7% -90.4% -- -- --
Current Ratio 1.62x 1.99x 1.82x 0.60x -- -- --
Quick Ratio 1.58x 1.95x 1.78x 0.55x -- -- --
Debt to Equity 0.86x 0.35x 0.24x -- -- -- --
Revenue Growth (YoY) -9.0% +36.5% -36.2% -- -- -- --
Gross Profit Growth (YoY) -33.2% +86.6% -62.1% -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001139685) · from December 31, 2024 Data through September 30, 2026 · synced Nov 21, 2026, 05:11 UTC · Open in terminal